USP7 and glioblastoma: By selectively targeting the USP7-MGMT interaction rather than globally inhibiting USP7, this strategy could enhance MGMT degradation, sensitize GBM cells to TMZ, and reduce the cytotoxicity associated with nonselective USP7 inhibition.